Related Experiment Video
Updated: Oct 13, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.4K
Indomethacin-Induced Headache: Causing the Problem You Are Trying to Solve
1Department of Neurology, MedStar Georgetown University Hospital, Hospital, 3800 Reservoir Road NW, 7-PHC, Washington, DC, 20007, USA. Carrie.O.Dougherty@gunet.georgetown.edu.
Current Pain and Headache Reports
|November 12, 2021
Summary
Indomethacin can cause drug-induced headaches, a rare side effect not often discussed in headache literature. Recognizing this is crucial for accurate diagnosis and treatment of headache disorders.
Area of Science:
- Neurology
- Pharmacology
Background:
- Indomethacin is a widely used medication for diagnosing and treating primary headache disorders.
- Its potential to induce headaches is often overlooked in clinical practice and literature.
Observation:
- A case study details a patient experiencing drug-induced headache following indomethacin treatment for trigeminal autonomic cephalgia.
- This highlights a potential adverse effect of indomethacin therapy.
Findings:
- Indomethacin, while beneficial for headaches, can paradoxically cause headaches.
- This drug-induced headache is a critical consideration in patient management.
Implications:
- Accurate identification of indomethacin-induced headache is vital for correct patient diagnosis.
- Understanding this adverse effect improves patient education and therapeutic response interpretation.
- This finding impacts the clinical use of indomethacin in headache management.
Related Concept Videos
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.1K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.1K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
416
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
416
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
533
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
533
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
292
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
292
01:25Analgesia and Pain Management
927
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
927
01:25Adrenergic Agonists: Indirect-Acting Agents
2.1K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.1K